OA08901A - Elaboration of host defense mediators into biological fluids by systemic DSRNA treatment. - Google Patents

Elaboration of host defense mediators into biological fluids by systemic DSRNA treatment.

Info

Publication number
OA08901A
OA08901A OA59407A OA59407A OA08901A OA 08901 A OA08901 A OA 08901A OA 59407 A OA59407 A OA 59407A OA 59407 A OA59407 A OA 59407A OA 08901 A OA08901 A OA 08901A
Authority
OA
OAPI
Prior art keywords
biological fluids
elaboration
host defense
various
systemic
Prior art date
Application number
OA59407A
Other languages
English (en)
Inventor
William A Carter
Original Assignee
Hem Res Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hem Res Inc filed Critical Hem Res Inc
Publication of OA08901A publication Critical patent/OA08901A/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H21/00—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Virology (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Communicable Diseases (AREA)
  • Biotechnology (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Epidemiology (AREA)
  • Genetics & Genomics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Saccharide Compounds (AREA)
  • Superconductors And Manufacturing Methods Therefor (AREA)
  • Breeding Of Plants And Reproduction By Means Of Culturing (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
OA59407A 1987-08-12 1988-08-12 Elaboration of host defense mediators into biological fluids by systemic DSRNA treatment. OA08901A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US8422787A 1987-08-12 1987-08-12

Publications (1)

Publication Number Publication Date
OA08901A true OA08901A (en) 1989-10-31

Family

ID=22183617

Family Applications (1)

Application Number Title Priority Date Filing Date
OA59407A OA08901A (en) 1987-08-12 1988-08-12 Elaboration of host defense mediators into biological fluids by systemic DSRNA treatment.

Country Status (19)

Country Link
EP (1) EP0308066B1 (de)
JP (1) JPH01131119A (de)
KR (1) KR0131879B1 (de)
CN (1) CN1050995C (de)
AT (1) ATE132041T1 (de)
AU (3) AU2053588A (de)
CA (1) CA1327002C (de)
DE (1) DE3854829T2 (de)
DK (1) DK449888A (de)
FI (1) FI883763L (de)
HU (1) HUT47854A (de)
IE (1) IE72103B1 (de)
IL (1) IL87413A0 (de)
NO (1) NO883594L (de)
NZ (1) NZ225799A (de)
OA (1) OA08901A (de)
PT (1) PT88266B (de)
RU (1) RU1834663C (de)
ZA (1) ZA885967B (de)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0306347B1 (de) * 1987-09-04 1995-05-10 Hem Pharmaceuticals Corp. Diagnose von Mangelzuständen doppelsträngiger RNS
US5593973A (en) * 1987-09-04 1997-01-14 Hemispherx Biopharma Inc. Treatment of viral hepatitis with mismatched dsRNA
US4963532A (en) * 1987-11-25 1990-10-16 Hem Research, Inc. dsRNA-based prevention of viral escape
JPH02504429A (ja) * 1988-05-23 1990-12-13 ガイ，ステファン リウマチ様関節炎の診断と治療
EP0473576A4 (en) * 1989-05-19 1993-03-10 Hem Research, Inc. Short therapeutic dsrna of defined structure
ZA908037B (en) * 1989-10-11 1991-09-25 Hem Res Inc Protection from shock subsequent to injury by double-standed rnas
WO1991005560A1 (en) * 1989-10-11 1991-05-02 Hem Research, Inc. PROTECTION FROM SHOCK SUBSEQUENT TO INJURY BY DOUBLE-STRANDED RNAs
EP0495831B1 (de) * 1989-10-16 1997-01-15 Hem Pharmaceuticals Corp. Diagnose und behandlung von neuro-cognitiven störungen assoziiert mit systemisch-immunologischer fehlfunktion
AU2554792A (en) * 1991-09-26 1993-04-27 Hem Pharmaceuticals Corp. Method of neutralizing il-1 using dsrnas
US6506559B1 (en) 1997-12-23 2003-01-14 Carnegie Institute Of Washington Genetic inhibition by double-stranded RNA
AUPP249298A0 (en) 1998-03-20 1998-04-23 Ag-Gene Australia Limited Synthetic genes and genetic constructs comprising same I
CN101818145A (zh) 1998-03-20 2010-09-01 联邦科学和工业研究组织 控制基因表达
CA2361201A1 (en) 1999-01-28 2000-08-03 Medical College Of Georgia Research Institute, Inc. Composition and method for in vivo and in vitro attenuation of gene expression using double stranded rna
US6423885B1 (en) 1999-08-13 2002-07-23 Commonwealth Scientific And Industrial Research Organization (Csiro) Methods for obtaining modified phenotypes in plant cells
US7638496B2 (en) 2000-02-15 2009-12-29 Valeant Pharmaceuticals North America Nucleoside analogs with carboxamidine modified monocyclic base
CA2369944A1 (en) 2001-01-31 2002-07-31 Nucleonics Inc. Use of post-transcriptional gene silencing for identifying nucleic acid sequences that modulate the function of a cell
EP1495120B1 (de) 2002-04-18 2012-10-10 Acuity Pharmaceuticals, Inc Mitteln und verfahren zur spezifischen modulation von zielgenen in dem auge
US7148342B2 (en) 2002-07-24 2006-12-12 The Trustees Of The University Of Pennyslvania Compositions and methods for sirna inhibition of angiogenesis
EP1551424B1 (de) 2002-09-04 2015-07-01 Arrowhead Research Corporation Behandlung von chronisch neuropathischen schmerzen durch verabreichung von dsrna
EP2134172A4 (de) * 2007-03-05 2011-06-01 Univ Utah State Restriktiver agonist des toll-like-rezeptors 3
AU2009322279A1 (en) 2008-12-04 2011-07-14 Opko Pharmaceuticals, Llc Compositions and methods for selective inhibition of pro-angiogenic VEGF isoforms
CN109355334A (zh) * 2018-12-06 2019-02-19 江苏省农业科学院 一种制备聚肌胞的方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1326450C (en) * 1985-08-26 1994-01-25 William A. Carter Modulation of aids virus-related events by double stranded rnas (dsrnas)
AU1820388A (en) * 1987-07-17 1989-01-19 Hem Research, Inc. Double stranded rna correction of aberrant metabolic pathways associated with uncontrolled tumor cell and virus growth cycles

Also Published As

Publication number Publication date
AU1001595A (en) 1995-02-23
HUT47854A (en) 1989-04-28
DK449888D0 (da) 1988-08-11
KR0131879B1 (ko) 1998-04-17
AU1736792A (en) 1992-07-30
NZ225799A (en) 1991-04-26
FI883763A7 (fi) 1989-02-13
RU1834663C (ru) 1993-08-15
NO883594D0 (no) 1988-08-12
CN1032740A (zh) 1989-05-10
ATE132041T1 (de) 1996-01-15
NO883594L (no) 1989-02-13
CN1050995C (zh) 2000-04-05
JPH01131119A (ja) 1989-05-24
DE3854829D1 (de) 1996-02-08
DK449888A (da) 1989-02-13
IE72103B1 (en) 1997-03-12
AU2053588A (en) 1989-04-20
KR890003402A (ko) 1989-04-14
PT88266B (pt) 1995-05-04
DE3854829T2 (de) 1996-08-14
IE882399L (en) 1989-02-12
FI883763A0 (fi) 1988-08-12
EP0308066A2 (de) 1989-03-22
CA1327002C (en) 1994-02-15
EP0308066B1 (de) 1995-12-27
ZA885967B (en) 1989-07-26
IL87413A0 (en) 1989-01-31
PT88266A (pt) 1989-06-30
EP0308066A3 (de) 1991-01-16
FI883763L (fi) 1989-02-13

Similar Documents

Publication Publication Date Title
IL87413A0 (en) Elaboration of host defense mediators into biological fluids by systemic dsrna treatment
KR900700094A (ko) 지방산과 모노글리세라이드의 항비루스 및 항세균 활성
DK345484D0 (da) Projektil til ildvaaben
EP0400958A3 (de) Lebende Impfstoffe
IE862276L (en) PREVENTION AND TREATMENT OF AIDS WITH dsRNA
BR0112919A (pt) Uso de óleos essenciais para combater infecção do trato gi por organismos semelhantes a helicobacter
GR3022801T3 (en) Phenylalkan(en)oic acids with leukotriene B4 antagonistic activity.
ES2053039T3 (es) Procedimiento para impedir el cambio de color de los alimentos.
ES2182847T3 (es) Nucleosidos y nucleotidos de anillo expandido.
DK178188A (da) Antivirusmiddel
KR900017587A (ko) 바이러스 감염증 치료제의 제조를 위한 티아졸 유도체 티프로티모드의 용도
DE69110470D1 (de) Herstellung von erhöhten Biokontrollwirkstoffen.
Wargo Interaction of stress and secondary organisms in decline of forest trees.
SU1727820A1 (ru) Способ стимул ции сперматогенеза у быков
ES8104402A1 (es) Procedimiento para la preparacion de medicamentos inmunobio-terapicos a partir de cepas microbiologicas.
DE69210737D1 (de) Verwendung von L-2-Oxothiazolidine-4-Carboxylate zur Herstellung eines Arzneimittels zur Behandlung von latenten HIV-Infektionen
PT83247B (pt) Processo para a preparacao de hidroxialquil-fenoxi-propan-2-olaminas uteis como beta-bloqueadores oculosselectivos
SU1069818A1 (ru) Способ профилактики гриппа
RU92015278A (ru) Средство, стабилизирующее витамины групп с, р, в и а и повышающее биологическую ценность пищевых продуктов
RU95116072A (ru) Способ повышения иммунологической защиты организма при смешанной инфекции ожоговой травмы
Pavlovskis et al. Experimental Pseudomonas aeruginosa infections in burned mice and rats: Description of a model.
Kosmidis TREATMENT OF SERIOUS INFECTIONS WITH CEFTRIAXONE
Kurnick et al. Effect of stilbamidine on ascites tumor of mice
Oomomo et al. Glucose nonfermentative gram-negative rods isolated from ocular infection.
RU92002700A (ru) Способ лечения острого подагрического артрита